top of page
Home
Platform
About
Pipeline
News
Careers
More
Use tab to navigate through the menu items.
Nov 7, 2024
4 min read
Dragonfly to Present Preclinical Data on Clinical-Stage DF6215, its Engineered IL-2R alpha-active Agonist, and DF9001, its EGFR-targeting TriNKET®, at SITC
Aug 5, 2024
2 min read
Dragonfly Therapeutics Appoints Dr. Susan Altschuller as Chief Financial Officer
May 21, 2024
2 min read
Dragonfly Announces Clinical Collaboration to Evaluate DF9001 in Combination with KEYTRUDA® in Patients with Solid Tumors
Mar 5, 2024
2 min read
Dragonfly has Received Milestone Payment Following Dosing of First Patient in AbbVie Phase 1 Clinical Trial Evaluating DF4101/ABBV-303
Feb 15, 2024
2 min read
Dragonfly Announces Clinical Collaboration Exploring Combinations of Dragonfly's DF1001 HER-2 TriNKET® with Gilead's Trodelvy® in two Cancer Indications
Dec 5, 2023
2 min read
Dragonfly Initiates Phase 1/1b Study of its IL-2 Immunotherapy
Aug 8, 2023
5 min read
One R.I. man’s battle with Stage 4 colon cancer
Jun 5, 2023
4 min read
Dragonfly Therapeutics Announces the Presentation of Phase 1 DF1001 TriNKET® Dose Escalation Results
Jun 1, 2023
2 min read
Dr. Robin Edwards and Dr. David Ferry join Dragonfly's Clinical Leadership Team
Apr 16, 2023
2 min read
Dragonfly Therapeutics Announces the Publication of Preclinical Data
Feb 5, 2023
2 min read
Dragonfly Announces it now owns all rights to its DF6002 novel IL12 cytokine
Feb 2, 2023
2 min read
Dr. Joseph E. Eid joins Dragonfly Therapeutics as President of R&D
Jan 6, 2023
2 min read
Dragonfly Therapeutics Announces Sixth Dragonfly TriNKET Opt-in by Bristol Myers Squibb
Dec 8, 2022
2 min read
Dragonfly Therapeutics Announces First Patient Dosed in Phase 1 Study of its EGFR-targeting TriNKETâ„¢
Dec 5, 2022
2 min read
Dragonfly Initiates Phase 2 Study of HER2 Targeting TriNKETâ„¢ DF1001
Nov 1, 2022
2 min read
Dragonfly Announces First Patient Dosed in Clinical Trial with Merck Evaluating Solid Tumor Target
May 1, 2022
1 min read
Gilead and Dragonfly Announce Strategic Research Collaboration to Develop NK Cell Engagers
Apr 20, 2022
2 min read
Dragonfly Announces Multi-Target Expansion of Research Collaboration with AbbVie
Mar 30, 2022
2 min read
Dragonfly Therapeutics Expands Clinical Leadership Team
Mar 1, 2022
1 min read
Bristol Myers partner comes through on IL-12 effort. Now it's Rupert Vessey's turn at bat
1
2
3
bottom of page